Harvard researchers call for a discussion and development of guidelines for 'embryoid' research, NPR reports.
In Science this week: a suite of studies from the Synthetic Yeast genome Project.
The worldwide distribution agreement expands Oxford's existing product and service portfolio, streamlining workflows for current customers, the company said.
The UN Convention on Biodiversity has rejected a moratorium on gene drives, Nature News says.
The company is hoping to find a niche among customers who want the quality of high-throughput oligonucleotide synthesis but smaller order volumes.
The President's Council of Advisors on Science and Technology urges the adoption of a biodefense strategy, Tech Review reports.
The company said it would use the funding to continue licensing its DNA design technology in the cell and gene therapy markets.
The DNA foundries have been funded through an £18 million ($23.5 million) investment from the BBSRC and should all be fully operational by next year.
In Science this week: effort to reduce E. coli genome, and more.
The Scientist traces the career path of the J. Craig Venter Institute's Clyde Hutchinson.
In PLOS this week: Mycobacterium abscessus linked to gastric conditions, placental gene expression changes associated with preterm birth, and more.
The Guardian reports that UK universities are looking into ways to reduce labs' reliance on single-use plastics.
People with certain gene variants tend to not like vegetables, particularly bitter ones, CNN reports.
MIT's Technology Review reports on a company's genetic test that gauges an embryo's susceptibility to certain diseases.